Finesse Solutions launches SmartFactory for single-use facilities

NewsGuard 100/100 Score

Finesse Solutions, Inc., Santa Clara, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the launch of SmartFactory, which is a uniquely configurable design architecture for single-use facilities. The Finesse SmartFactory is based on Finesse SmartParts, the measurement and actuation building blocks which comprise SmartSystem process automation solutions. Finesse now proudly introduces SmartMES, a complete operations-management solution for the Finesse SmartFactory.

SmartFactory has been designed with an open architecture that leverages Finesse SmartSystem universal controllers. This enables the process flow to be designed with user-preferred equipment in a modular and scalable manner, while fully maintaining quality and regulatory compliance in the electronic batch records. SmartFactory implementation is completely flexible, so that the user can focus on the level of automation required for each unit operation and the consistency of single-use film materials between upstream and downstream, without compromising the project budget or timeline. SmartFactory is based on the DeltaV© control and batch platforms from Emerson Process Management.

SmartMES optimizes plant-wide resource utilization, integrates manufacturing batch information, and facilitates training and validation record management. SmartMES is a COTS Level 3 solution based on the seamless integration of Finesse upstream (TruBio©) and downstream (TruPurTM, / TruChromTM) GAMP5 process control software.

"As the challenges in biologics and vaccine manufacturing increase with fewer blockbuster drugs, emerging markets, patent expiration, shorter time-to-market, reimbursement price pressure, and increased regulatory complexity, companies are turning to multi-product single-use facilities. These facilities can provide higher yield production with fewer employees at a greatly reduced capital expenditure. They also, however, require far greater operations management system flexibility," stated Dr. Barbara Paldus, CEO of Finesse Solutions. "Our SmartFactory platform is highly flexible and configurable so that it can serve customer needs for both newly developed products in a pilot plant providing clinical materials, to well-understood large scale commercial production in BRIC countries."

SOURCE Finesse Solutions, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Columbia researchers secure $38.95 million ARPA-H contract to build a living knee replacement